In our podcast series, Embracing Disruption, senior IP Analyst Lynne Teo discusses key themes happening in innovation and tech
"The Australian Government wants to financially reward companies who invest in R&D. We make this process easier."
“R&D is good for your company (that’s the reason you do it). R&D is good for the economy (that’s the reason the government supports it)”, says David. “Clients are pleasantly surprised when they realise that the government is strongly motivated to financially incentivise them to invest in R&D.”
David’s approach is to develop a thorough and intimate knowledge of your business and then develop a tailored R&D tax preparation and lodgement process that maximises the financial return a company is able to access. More importantly though, David will also develop a solution that dovetails into your company’s existing structure and record keeping processes in order to minimise the internal time and resources required to be devoted to completing the R&D claim process.
David’s intellectual property academic qualifications, background and professional affiliations provides him with a unique ability to maximise value at every stage along the innovation pathway.
As well as helping Australia-based clients, David and his team assist small international biotech companies set up research and development activities in Australia. “Our favourable R&D Tax Incentive program, whereby almost half of all drug development costs may be eligible to be refunded by the government, combined with a thriving biotech industry means Australia is an attractive location for start-up biotech companies looking to undertake clinical trials.”
Additionally, David is a registered Trade Marks Attorney and registered Taxation Agent (R&D Tax).